TY - JOUR
T1 - Bisphosphonate und Kiefernekrose--eine zunehmende Herausforderung in der Palliativmedizin
AU - Beke, Dora
AU - Pecherstorfer, Martin
PY - 2008
Y1 - 2008
N2 - Bone metastases are one of the most common complications of cancer. Up to 70% of patients with advanced breast cancer metastasize to the bone. The standard long-term treatment of bone metastases is bisphosphonates. This effective therapy, however, is able to cause serious side effects. Osteonecrosis of the jaw (ONJ) is a recently detected adverse outcome associated in rare cases with bisphosphonate therapy.
AB - Bone metastases are one of the most common complications of cancer. Up to 70% of patients with advanced breast cancer metastasize to the bone. The standard long-term treatment of bone metastases is bisphosphonates. This effective therapy, however, is able to cause serious side effects. Osteonecrosis of the jaw (ONJ) is a recently detected adverse outcome associated in rare cases with bisphosphonate therapy.
KW - Bone Density Conservation Agents/adverse effects
KW - Bone Neoplasms/secondary
KW - Breast Neoplasms/therapy
KW - Carcinoma, Ductal/secondary
KW - Combined Modality Therapy
KW - Diphosphonates/adverse effects
KW - Disease Progression
KW - Female
KW - Humans
KW - Image Processing, Computer-Assisted
KW - Imaging, Three-Dimensional
KW - Mandibular Diseases/chemically induced
KW - Maxillary Diseases/chemically induced
KW - Middle Aged
KW - Neoplasm Recurrence, Local/therapy
KW - Osteonecrosis/chemically induced
KW - Tomography, X-Ray Computed
KW - Osteonecrosis of the jaw
KW - Bisphosphonates
KW - Bone metastasis
UR - http://www.scopus.com/inward/record.url?scp=64149094346&partnerID=8YFLogxK
U2 - 10.1007/s10354-008-0630-z
DO - 10.1007/s10354-008-0630-z
M3 - Artikel in Fachzeitschrift
C2 - 19165450
SN - 0043-5341
VL - 158
SP - 702
EP - 706
JO - Wiener Medizinische Wochenschrift
JF - Wiener Medizinische Wochenschrift
IS - 23-24
ER -